Folgen
Amirhossein Modabbernia, MD, PhD, Assistant Professor of Psychiatry
Amirhossein Modabbernia, MD, PhD, Assistant Professor of Psychiatry
Department of Psychiatry, Mount Sinai School of Medicine
Bestätigte E-Mail-Adresse bei mssm.edu
Titel
Zitiert von
Zitiert von
Jahr
Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses
A Modabbernia, E Velthorst, A Reichenberg
Molecular autism 8, 1-16, 2017
8152017
Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies
A Modabbernia, S Taslimi, E Brietzke, M Ashrafi
Biological psychiatry 74 (1), 15-25, 2013
6542013
Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study
SH Abbasi, F Hosseini, A Modabbernia, M Ashrafi, S Akhondzadeh
Journal of affective disorders 141 (2-3), 308-314, 2012
3592012
Laughter yoga versus group exercise program in elderly depressed women: a randomized controlled trial
M Shahidi, A Mojtahed, A Modabbernia, M Mojtahed, A Shafiabady, ...
International journal of geriatric psychiatry 26 (3), 322-327, 2011
3192011
Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial
A Modabbernia, H Sohrabi, AA Nasehi, F Raisi, S Saroukhani, A Jamshidi, ...
Psychopharmacology 223, 381-388, 2012
2032012
Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3–90 years
S Frangou, A Modabbernia, SCR Williams, E Papachristou, GE Doucet, ...
Human brain mapping 43 (1), 431-451, 2022
1792022
Saffron for treatment of fluoxetine‐induced sexual dysfunction in women: randomized double‐blind placebo‐controlled study
L Kashani, F Raisi, S Saroukhani, H Sohrabi, A Modabbernia, AA Nasehi, ...
Human Psychopharmacology: Clinical and Experimental 28 (1), 54-60, 2013
1722013
Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study
A Ghaleiha, N Entezari, A Modabbernia, B Najand, N Askari, M Tabrizi, ...
Journal of psychiatric research 47 (2), 175-180, 2013
1682013
Natural history of cavernous malformation: systematic review and meta-analysis of 25 studies
S Taslimi, A Modabbernia, S Amin-Hanjani, FG Barker, RL Macdonald
Neurology 86 (21), 1984-1991, 2016
1632016
Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial
K Sepanjnia, A Modabbernia, M Ashrafi, MJ Modabbernia, ...
Neuropsychopharmacology 37 (9), 2093-2100, 2012
1552012
Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
M Asadabadi, MR Mohammadi, A Ghanizadeh, A Modabbernia, M Ashrafi, ...
Psychopharmacology 225, 51-59, 2013
1322013
Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia: an 8-week, randomized, double-blind, placebo-controlled study
A Modabbernia, F Rezaei, B Salehi, M Jafarinia, M Ashrafi, M Tabrizi, ...
CNS drugs 27, 57-65, 2013
1282013
Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome …
L Kashani, T Omidvar, B Farazmand, A Modabbernia, F Ramzanzadeh, ...
Psychoneuroendocrinology 38 (6), 767-776, 2013
1252013
Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: randomized double-blind placebo-controlled study
A Modabbernia, P Heidari, R Soleimani, A Sobhani, ZA Roshan, S Taslimi, ...
Journal of psychiatric research 53, 133-140, 2014
1152014
Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania
Z Amrollahi, F Rezaei, B Salehi, AH Modabbernia, A Maroufi, ...
Journal of affective disorders 129 (1-3), 327-331, 2011
1132011
Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study
MR Khodaie-Ardakani, O Mirshafiee, M Farokhnia, M Tajdini, ...
Psychiatry research 215 (3), 540-546, 2014
1082014
Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study
D Khajavi, M Farokhnia, A Modabbernia, M Ashrafi, SH Abbasi, M Tabrizi, ...
Journal of Clinical Psychiatry 73 (11), 1428, 2012
1062012
Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3–90 years
D Dima, A Modabbernia, E Papachristou, GE Doucet, I Agartz, M Aghajani, ...
Human brain mapping 43 (1), 452-469, 2022
972022
Impaired gas exchange at birth and risk of intellectual disability and autism: a meta-analysis
A Modabbernia, J Mollon, P Boffetta, A Reichenberg
Journal of autism and developmental disorders 46, 1847-1859, 2016
812016
Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial
N Askari, M Moin, M Sanati, M Tajdini, SMR Hosseini, A Modabbernia, ...
CNS drugs 26, 883-892, 2012
792012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20